{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:41:49Z","timestamp":1770748909827,"version":"3.50.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T00:00:00Z","timestamp":1667174400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.ijbiomac.2022.10.105","type":"journal-article","created":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T13:03:59Z","timestamp":1665752639000},"page":"79-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["CRM197-conjugated multi antigen dominant epitope for effective human cytomegalovirus vaccine development"],"prefix":"10.1016","volume":"224","author":[{"given":"Shasha","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fulong","family":"Nan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianjuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zonghui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongjie","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengjun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqiong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delei","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenxuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoli","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0005","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/s41579-021-00582-z","article-title":"Pathogenesis of human cytomegalovirus in the immunocompromised host","volume":"19","author":"Griffiths","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.680559","article-title":"Dominant antiviral CD8(+) T cell responses empower prophylactic antibody-eliciting vaccines against cytomegalovirus","volume":"13","author":"Pardieck","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0015","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.vaccine.2004.06.038","article-title":"Lack of induction of autoantibody responses following immunization with cytomegalovirus (CMV) glycoprotein B (gB) in healthy CMV-seronegative subjects","volume":"23","author":"Schleiss","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0020","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.molmed.2005.11.006","article-title":"Human cytomegalovirus vaccine: time to look for alternative options","volume":"12","author":"Khanna","year":"2006","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0025","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jcmgh.2022.05.002","article-title":"Human cytomegalovirus-IE2 affects embryonic liver development and survival in transgenic mouse","volume":"14","author":"Zhang","year":"2022","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0030","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.3389\/fimmu.2019.02110","article-title":"The roles of host and viral antibody fc receptors in herpes simplex virus (HSV) and human cytomegalovirus (HCMV) infections and immunity","volume":"10","author":"Jenks","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0035","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1038\/s41467-019-10865-y","article-title":"Human cytomegalovirus evades antibody-mediated immunity through endoplasmic reticulum-associated degradation of the FcRn receptor","volume":"10","author":"Liu","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0040","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/cmi.2014.75","article-title":"The immunology of human cytomegalovirus latency: could latent infection be cleared by novel immunotherapeutic strategies?","volume":"12","author":"Wills","year":"2015","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0045","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1182\/blood-2005-11-012864","article-title":"Prospective simultaneous quantification of human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in young recipients of allogeneic hematopoietic stem cell transplants","volume":"108","author":"Lilleri","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0050","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191164","article-title":"Identification of HCMV-derived T cell epitopes in seropositive individuals through viral deletion models","volume":"217","author":"L\u00fcbke","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0055","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nri.2016.38","article-title":"T cell responses to cytomegalovirus","volume":"16","author":"Klenerman","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0060","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1084\/jem.20050882","article-title":"Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects","volume":"202","author":"Sylwester","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0065","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1093\/nar\/12.10.4063","article-title":"The amino-acid sequence of two non-toxic mutants of diphtheria toxin: CRM45 and CRM197","volume":"12","author":"Giannini","year":"1984","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0070","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1021\/acs.molpharmaceut.6b00138","article-title":"Conjugation with an inulin-chitosan adjuvant markedly improves the immunogenicity of Mycobacterium tuberculosis CFP10-TB10.4 fusion protein","volume":"13","author":"Yu","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0075","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nri2494","article-title":"Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines","volume":"9","author":"Pollard","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0080","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ijbiomac.2021.08.177","article-title":"Conjugation of zika virus EDIII with CRM(197), 8-arm PEG and mannan for development of an effective Zika virus vaccine","volume":"190","author":"He","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0085","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41541-017-0038-0","article-title":"Complement enhances in vitro neutralizing potency of antibodies to human cytomegalovirus glycoprotein B (gB) and immune sera induced by gB\/MF59 vaccination","volume":"2","author":"Li","year":"2017","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0090","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1073\/pnas.1800177115","article-title":"HCMV glycoprotein B subunit vaccine efficacy mediated by nonneutralizing antibody effector functions","volume":"115","author":"Nelson","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0095","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.1016\/j.vaccine.2008.07.092","article-title":"Cytomegalovirus vaccines fail to induce epithelial entry neutralizing antibodies comparable to natural infection","volume":"26","author":"Cui","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0100","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.vaccine.2015.11.056","article-title":"Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: a randomized clinical trial","volume":"34","author":"Bernstein","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0105","doi-asserted-by":"crossref","first-page":"10960","DOI":"10.1128\/JVI.78.20.10960-10966.2004","article-title":"Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome","volume":"78","author":"Varnum","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0110","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1034\/j.1399-0039.2003.00062.x","article-title":"New allele frequency database","volume":"61","author":"Middleton","year":"2003","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0115","doi-asserted-by":"crossref","first-page":"5831","DOI":"10.4049\/jimmunol.1302101","article-title":"HLA class I alleles are associated with peptide-binding repertoires of different size, affinity, and immunogenicity","volume":"191","author":"Paul","year":"2013","journal-title":"J. Immunology (Baltimore, Md. : 1950)"},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0120","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.4049\/jimmunol.1700893","article-title":"NetMHCpan-4.0: improved peptide-MHC class I interaction predictions integrating eluted ligand and peptide binding affinity data","volume":"199","author":"Jurtz","year":"2017","journal-title":"Journal of immunology (Baltimore, Md. : 1950)"},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10091564","article-title":"Multi-epitope-based vaccine candidate for monkeypox: an in silico approach","volume":"10","author":"Abdi","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0130","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/hep.21658","article-title":"Cytochrome P450IID6-specific CD8 T cell immune responses mirror disease activity in autoimmune hepatitis type 2","volume":"46","author":"Longhi","year":"2007","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0135","doi-asserted-by":"crossref","first-page":"W513","DOI":"10.1093\/nar\/gkn254","article-title":"Immune epitope database analysis resource (IEDB-AR)","volume":"36","author":"Zhang","year":"2008","journal-title":"Nucleic Acids Research"},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.863234","article-title":"Immunoinformatic design of a multivalent peptide vaccine against mucormycosis: targeting FTR1 protein of major causative fungi","volume":"13","author":"Araf","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0145","article-title":"Newcastle disease virus inhibits the proliferation of T cells induced by dendritic cells in vitro and in vivo","volume":"11","author":"Nan","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0150","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00186-20","article-title":"Human cytomegalovirus glycoprotein B nucleoside-modified mRNA vaccine elicits antibody responses with greater durability and breadth than MF59-adjuvanted gB protein immunization","volume":"94","author":"Nelson","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0155","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jviromet.2005.05.005","article-title":"Rapid human metapneumovirus microneutralization assay based on green fluorescent protein expression","volume":"128","author":"Biacchesi","year":"2005","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0160","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/rmv.1735","article-title":"Contribution of dendritic cells to measles virus induced immunosuppression","volume":"23","author":"Coughlin","year":"2013","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0165","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s00109-004-0620-6","article-title":"Reading the viral signature by toll-like receptors and other pattern recognition receptors","volume":"83","author":"Mogensen","year":"2005","journal-title":"J. Mol. Med. (Berlin, Germany)"},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0170","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/s41422-021-00495-9","article-title":"SARS-CoV-2 spike protein interacts with and activates TLR41","volume":"31","author":"Zhao","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0175","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41586-021-03861-0","article-title":"An engineered IL-2 partial agonist promotes CD8(+) T cell stemness","volume":"597","author":"Mo","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0180","doi-asserted-by":"crossref","first-page":"14309","DOI":"10.1073\/pnas.1835673100","article-title":"Murine cytomegalovirus paralyzes macrophages by blocking IFN gamma-induced promoter assembly","volume":"100","author":"Popkin","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0185","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.1128\/JVI.00082-08","article-title":"Uniocular anterior chamber inoculation of a tumor necrosis factor alpha-expressing recombinant of herpes simplex virus type 1 results in more rapid destruction and increased viral replication in the retina of the uninoculated eye","volume":"82","author":"Fields","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0190","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0195","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0200","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ni909","article-title":"An essential role for scurfin in CD4+CD25+ T regulatory cells","volume":"4","author":"Khattri","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0205","doi-asserted-by":"crossref","first-page":"937","DOI":"10.15585\/mmwr.mm6842a1","article-title":"Global Routine Vaccination Coverage, 2018","volume":"68","author":"Peck","year":"2019","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0210","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1021\/acs.chemrev.9b00472","article-title":"Peptide-based vaccines: current progress and future challenges","volume":"120","author":"Malonis","year":"2020","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0215","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.2217\/nnm.14.187","article-title":"Recent advances in peptide-based subunit nanovaccines","volume":"9","author":"Skwarczynski","year":"2014","journal-title":"Nanomedicine (London, England)"},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0220","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41541-021-00347-y","article-title":"An epitope-specific chemically defined nanoparticle vaccine for respiratory syncytial virus","volume":"6","author":"Zuniga","year":"2021","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0225","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1182\/bloodadvances.2017014175","article-title":"Phase 2 trial of a multivalent WT1 peptide vaccine (galinpepimut-S) in acute myeloid leukemia","volume":"2","author":"Maslak","year":"2018","journal-title":"Blood Adv."},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0230","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nrc2373","article-title":"Immunotherapy of established (pre)malignant disease by synthetic long peptide vaccines","volume":"8","author":"Melief","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0235","doi-asserted-by":"crossref","first-page":"5229","DOI":"10.1073\/pnas.1201964109","article-title":"Structural basis for lack of toxicity of the diphtheria toxin mutant CRM197","volume":"109","author":"Malito","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0240","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jconrel.2010.01.007","article-title":"Conjugation of ovalbumin to trimethyl chitosan improves immunogenicity of the antigen","volume":"143","author":"Sl\u00fctter","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0245","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41590-021-00869-6","article-title":"Inflammasomes and adaptive immune responses","volume":"22","author":"Deets","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0250","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/79734","article-title":"Dendritic cell regulation of TH1-TH2 development","volume":"1","author":"Moser","year":"2000","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0255","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.7150\/ijbs.58127","article-title":"Insight for immunotherapy of HCMV infection","volume":"17","author":"Long","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0260","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1038\/s41385-018-0041-4","article-title":"Cytomegalovirus promotes intestinal macrophage-mediated mucosal inflammation through induction of Smad7","volume":"11","author":"Dennis","year":"2018","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0265","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.smim.2003.10.003","article-title":"TLR signaling pathways","volume":"16","author":"Takeda","year":"2004","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0270","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.immuni.2011.05.006","article-title":"Toll-like receptors and their crosstalk with other innate receptors in infection and immunity","volume":"34","author":"Kawai","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0275","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ijbiomac.2020.04.097","article-title":"Vaccinomics strategy to concoct a promising subunit vaccine for visceral leishmaniasis targeting sandfly and Leishmania antigens","volume":"156","author":"Ojha","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120342","article-title":"Adaptable antigen matrix platforms for peptide vaccination strategies and T cell-mediated anti-tumor immunity","volume":"262","author":"Schetters","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijbiomac.2022.10.105_bb0285","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1182\/blood-2012-07-409755","article-title":"The split personality of regulatory T cells in HIV infection","volume":"121","author":"Chevalier","year":"2013","journal-title":"Blood"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813022023510?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813022023510?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T09:49:37Z","timestamp":1758880177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813022023510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":57,"alternative-id":["S0141813022023510"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.10.105","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CRM197-conjugated multi antigen dominant epitope for effective human cytomegalovirus vaccine development","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.10.105","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}